The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer

Clinical trial NCT00268840 · COMPLETED

Trial details

NCT number: NCT00268840
Sponsor: ARCAGY/ GINECO GROUP
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Neoplasms Biliary Tract Neoplasms

Start date: 2001-08-01
Primary completion: 2006-02-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.